Dr. Wanda Phipatanakul, Associate Professor of Pediatrics at Harvard Medical School and Director/Principal Investigator (PI) of the NIH funded Asthma/Allergy Clinical Research Center at Boston Children’s Hospital received her medical degree at Loma Linda University in California. She did her pediatric residency Children’s Hospital of Los Angeles allergy fellowship at Johns Hopkins University in Baltimore, before taking a faculty position at Harvard, where she received a Masters in Clinical Epidemiology from the Harvard School of Public Health. Dr. Phipatanakul leads her own school and home-based community inner-city asthma studies and is Boston Pediatric PI of NIH funded asthma clinical research networks tackling practice management knowledge gaps. She also utilizes the knowledge from these clinical research studies to provide evidence-based care for her patients, whom she sees primarily at Boston Children’s Hospital. Her research interests also include early interventions in young children, particularly prevention, immunologic/biologics, and other interventions targeted towards the allergic, asthma pathway. She will be leading in the near future a 7 year, multi- center NIH asthma prevention grant evaluating anti-IgE therapy in at risk toddlers, and leads the Boston Site on another multi-center primary prevention study utilizing killed bacterial lysate in babies. She was also recently awarded as Boston site PI on validation instruments in asthma, food allergy, atopic dermatitis, and chronic diseases. Dr. Phipatanakul’s long-standing relationship with community, comprehensively evaluating the role of school-specific exposures and asthma, allergies, and food allergies allows her to work towards incorporating public policy and school-based asthma/allergy management initiatives. She has published over 150 articles in various scientific journals, and leads the American Academy of Allergy, Asthma, and Immunology (AAAAI) Environmental Occupational Respiratory Disorders Interest Section and the AAAAI Interest Section Coordinating Committee. Her main passion is teaching and mentoring, and she was awarded mentoring awards from the Thai Association Physician Foundation, Harvard Medical School, the Pediatric Academic Society, and holds a mid-career NIH mentoring award to support her teaching and mentoring efforts.

Ian M. Paul, M.D., M.Sc. Dr. Ian M. Paul is a Professor of Pediatrics and Public Health Sciences at the Pennsylvania State University College of Medicine. He is also Chief of the Division of Academic General Pediatrics and Vice Chair of Clinical Affairs in the Department of Pediatrics at Penn State Hershey Children’s Hospital. Dr. Paul is a general pediatrician and clinical and health services researcher with principal interests in a) primary preventive interventions for newborns, infants, and families and b) clinical therapeutics for children. His research focuses on these two areas with the largest current NIH/NIDDK-funded projects focusing on the prevention of childhood obesity through home-based interventions delivered to parents of infants. His work in this field includes the first ever study to demonstrate that behavioral interventions delivered in the months after birth can lead to slower weight gain through age 1 year. He also is funded by HRSA/MCHB on projects related to newborn weight loss and breastfeeding, research that generated the first ever nomograms depicting newborn weight loss for exclusively breastfed and exclusively formula fed term neonates during the birth hospitalization (www.newbornweight.org). Dr. Paul is and has been a co- investigator on numerous NIH-funded projects related to co-parenting, infant sleep, prevention of Shaken Baby Syndrome, prevention of adverse pregnancy outcomes and the treatment of asthma, the latter through participation as a co-investigator on the NHLBI-funded network, AsthmaNet. Dr. Paul has held leadership positions with the American Academy of Pediatrics including service on the Committee on Drugs (2010-2016). He also is a steering committee member for the NIH’s Pediatric Trials Network (PTN) as well as a participant in the CDC’s PROTECT initiative, which seeks to prevent unintended ingestions and overdoses of medications by children. His role on these committees reflects his experience with pediatric clinical therapeutics and medications for children. In particular, Dr. Paul is an internationally recognized expert on the pediatric treatment of the common cold and its symptoms having led numerous investigations related to cough/cold medications and antipyretics. A clinician as well, Dr. Paul has a thriving general pediatric practice where he provides medical care for children from birth through age 21 years. He has been recognized several times for superior patient satisfaction. Dr. Paul received his B.A. from Franklin and Marshall College (cum laude) with a major in Chemistry (with honors), received both graduate degrees (M.D. and M.Sc.) from The Penn State College of Medicine, and completed his pediatric residency at Duke

Dr. William Sheehan is a physician in the Allergy and Immunology Division at Boston Children's Hospital. He is also an Instructor of Pediatrics at Harvard Medical School. He is one of the Principal Investigators for the AVICA trial (Acetaminophen vs. Ibuprofen in Children with Asthma). In addition to asthma, his research focuses on environmental exposures and food allergies. He currently receives research funding from the NIH, National Institute of Allergy and Infectious Diseases (NIAID).